Healthcare provider knowledge, attitudes, and preferences in management of genitourinary syndrome of menopause in the Mid-South

被引:6
作者
Morris, Joshua [1 ]
Clark, Cassidy [1 ]
Reed, Laura [2 ]
Pace, Diane [1 ,2 ]
Cao, Xueyuan [2 ]
Khanna, Pallavi [1 ]
机构
[1] Univ Tennessee, Dept Obstet & Gynecol, Hlth Sci Ctr, Memphis, TN 38103 USA
[2] Univ Tennessee, Coll Nursing, Hlth Sci Ctr, Memphis, TN 38103 USA
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2021年 / 28卷 / 11期
关键词
Genitourinary syndrome of menopause; Menopause; Vaginal estrogen; Vulvar and vaginal symptoms; DOSE VAGINAL ESTROGEN; POSTMENOPAUSAL WOMEN; HORMONE-THERAPY; ATROPHY; PATTERNS; SOCIETY; VULVAR; VIEWS;
D O I
10.1097/GME.0000000000001847
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study explored the clinical management practices of healthcare providers who treat menopausal women in an urban Mid-South area. The study specifically examined their knowledge of prescribing and counseling related to the care of women who present with complaints or clinical findings of genitourinary syndrome of menopause. Methods: An electronic questionnaire was distributed to healthcare providers involved in the care of women undergoing menopausal transition spanning a variety of medical specialties. The questionnaire was distributed to academic program directors, coordinators, and ListServ administrators to forward to targeted respondents. Items included demographic questions, clinical knowledge, management practices, and preferences. Statistical analysis for associations between demographics was performed using Chi-squared tests and between age groups with Kruskal Wallis tests. Results: The final sample contained 106 healthcare providers. Respondents were demographically diverse and encompassed multiple levels of professional training including Attendings, Trainees (Residents and Fellows), as well as Advanced Practice Registered Nurses. Significant differences were noted in many areas examined in our questionnaire, comprising knowledge, management, counseling, and prescribing practices surrounding the treatment of genitourinary syndrome of menopause when accounting for training level, specialty, and years in practice. Among all respondents, 10.4% reported rarely or never discussing menopausal symptoms with their patients. Most respondents (76.4%) stated they had prescribed topical therapies for genitourinary syndrome of menopause, with over 90% of practitioners prescribing lubricants/moisturizers and estradiol cream; however, only 55% reported being familiar with the US Food and Drug Administration's boxed warning on low-dose vaginal estrogen. Nearly half of the respondents (49%) reported being uncomfortable counseling about the boxed warning on low-dose vaginal estrogen. Conclusion: This study identifies gaps in Mid-South healthcare providers' awareness of the boxed warning on low-dose vaginal estrogen as well as their comfort level in providing counseling regarding the risks, benefits, and alternatives to vaginal estrogen. Integrated practice between physicians and Advanced Practice Registered Nurses can lead to a significant benefit to patients experiencing menopause as shared experience and knowledge are shared between each group. Our survey does reveal gaps in knowledge and practice for optimal outcomes for patients experiencing genitourinary syndrome of menopause. These results will be useful in providing continuing education to providers and more effective communication, evaluation, and treatment to patients.
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 35 条
  • [21] Fractional CO2 Laser Treatment Is Safe and Effective for the Management of Genitourinary Syndrome of Menopause in Korean Women
    Chung, Youn-Jee
    Shim, Suhyun
    Kim, Sejin
    Cha, Jimin
    Song, Jae-Yen
    Kim, Min Jeong
    Kim, Mee-Ran
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [22] Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review
    Mejia-Gomez, J.
    Bouteaud, J.
    Philippopoulos, E.
    Wolfman, W.
    Brezden-Masley, C.
    CLIMACTERIC, 2022, 25 (03) : 228 - 234
  • [23] Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype?
    Anastasios Tranoulis
    Dimitra Georgiou
    Lina Michala
    International Urogynecology Journal, 2019, 30 : 1879 - 1886
  • [24] Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study
    Gaspar, Adrian
    Maestri, Sandra
    Silva, Joaquin
    Brandi, Hugo
    Luque, Daniel
    Koron, Neza
    Vizintin, Zdenko
    LASERS IN SURGERY AND MEDICINE, 2018, 50 (08) : 802 - 807
  • [25] Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype?
    Tranoulis, Anastasios
    Georgiou, Dimitra
    Michala, Lina
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 (11) : 1879 - 1886
  • [26] Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
    Faubion, Stephanie S.
    Larkin, Lisa C.
    Stuenkel, Cynthia A.
    Bachmann, Gloria A.
    Chism, Lisa A.
    Kagan, Risa
    Kaunitz, Andrew M.
    Krychman, Michael L.
    Parish, Sharon J.
    Partridge, Ann H.
    Pinkerton, JoAnn V.
    Rowen, Tami S.
    Shapiro, Marla
    Simon, James A.
    Goldfarb, Shari B.
    Kingsberg, Sheryl A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (06): : 596 - 608
  • [27] Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
    Laura Baquedano Mainar
    Sonia Sánchez Méndez
    Peña Dieste Pérez
    Mónica Hernández Aragón
    Nicolás Mendoza Ladrón de Guevara
    BMC Women's Health, 21
  • [28] CO2 Laser versus Sham Control for the Management of Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Prodromidou, Anastasia
    Zacharakis, Dimitrios
    Athanasiou, Stavros
    Kathopoulis, Nikolaos
    Varthaliti, Antonia
    Douligeris, Athanasios
    Michala, Lina
    Athanasiou, Veatriki
    Salvatore, Stefano
    Grigoriadis, Themos
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (12):
  • [29] Vaginal CO2 laser therapy versus sham for genitourinary syndrome of menopause management: a systematic review and meta-analysis of randomized controlled trials
    Khamis, Yasser
    Mohamed Abdelhakim, Ahmed
    Labib, Kareem
    Aly Islam, Bassem
    Ashraf Nassar, Salma
    Abdel Motaal, Ahmed Osama
    Saleh, Doaa M.
    Abdou, Hossam
    Abbas, Ahmed M.
    Mojahed, Eman M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (11): : 1316 - 1322
  • [30] Efficacy and safety of carbon dioxide laser therapy compared with sham for genitourinary syndrome of menopause management: a meta-analysis of randomized clinical trials
    Gunawan, Yuliana W.
    Erlina, Yunita
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (09): : 980 - 987